{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:08:01Z","timestamp":1793286481710,"version":"4.5.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG06173"],"award-info":[{"award-number":["AG06173"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG015379"],"award-info":[{"award-number":["AG015379"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000319","name":"ARUK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2016,6,1]]},"DOI":"10.15252\/emmm.201606210","type":"journal-article","created":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T23:01:20Z","timestamp":1459292480000},"page":"595-608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5944,"title":["The amyloid hypothesis of Alzheimer's disease at 25\u00a0years"],"prefix":"10.1038","volume":"8","author":[{"given":"Dennis J","family":"Selkoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,29]]},"reference":[{"key":"BFEMMM201606210_CR1","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1073\/pnas.0503689102","volume":"102","author":"OM Andersen","year":"2005","unstructured":"Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, von Arnim CA, Breiderhoff T, Jansen P, Wu X et\u00a0al (2005) Neuronal sorting protein\u2010related receptor sorLA\/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci U S A 102: 13461\u201313466","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFEMMM201606210_CR2","doi-asserted-by":"crossref","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","volume":"30","author":"Y Andrews\u2010Zwilling","year":"2010","unstructured":"Andrews\u2010Zwilling Y, Bien\u2010Ly N, Xu Q, Li G, Bernardo A, Yoon SY, Zwilling D, Yan TX, Chen L, Huang Y (2010) Apolipoprotein E4 causes age\u2010 and Tau\u2010dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J Neurosci 30: 13707\u201313717","journal-title":"J Neurosci"},{"key":"BFEMMM201606210_CR3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4088\/JCP.13m08927","volume":"75","author":"N Ayutyanont","year":"2014","unstructured":"Ayutyanont N, Langbaum JB, Hendrix SB, Chen K, Fleisher AS, Friesenhahn M, Ward M, Aguirre C, Acosta\u2010Baena N, Madrigal L et\u00a0al (2014) The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers. J Clin Psychiatry 75: 652\u2013660","journal-title":"J Clin Psychiatry"},{"key":"BFEMMM201606210_CR4","first-page":"212","volume":"535","author":"XC Bai","year":"2015","unstructured":"Bai XC, Yan C, Yang G, Lu P, Ma D, Sun LD, Zhou R, Scheres SH, Shi Y (2015) An atomic structure of human gamma\u2010secretase. Nature 535: 212\u2013217","journal-title":"Nature"},{"key":"BFEMMM201606210_CR5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson\u2010Wood K et\u00a0al (2000) Peripherally administered antibodies against amyloid beta\u2010peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6: 916\u2013919","journal-title":"Nat Med"},{"key":"BFEMMM201606210_CR6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm1438","volume":"12","author":"RJ Bateman","year":"2006","unstructured":"Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM (2006) Human amyloid\u2010beta synthesis and clearance rates as measured in cerebrospinal fluid in\u00a0vivo. Nat Med 12: 856\u2013861","journal-title":"Nat Med"},{"key":"BFEMMM201606210_CR7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM et\u00a0al (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367: 795\u2013804","journal-title":"N Engl J Med"},{"key":"BFEMMM201606210_CR8","doi-asserted-by":"crossref","first-page":"30977","DOI":"10.1074\/jbc.M114.599027","volume":"289","author":"I Benilova","year":"2014","unstructured":"Benilova I, Gallardo R, Ungureanu AA, Castillo Cano V, Snellinx A, Ramakers M, Bartic C, Rousseau F, Schymkowitz J, De Strooper B (2014) The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid\u2010beta (Abeta) aggregation. J Biol Chem 289: 30977\u201330989","journal-title":"J Biol Chem"},{"key":"BFEMMM201606210_CR9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BM, Hooli B, Divito J, Ionita I et\u00a0al (2008) Genome\u2010wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet 83: 623\u2013632","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201606210_CR10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1750-3639.1991.tb00667.x","volume":"1","author":"K Beyreuther","year":"1991","unstructured":"Beyreuther K, Masters CL (1991) Amyloid precursor protein (APP) and beta A4 amyloid in the etiology of Alzheimer's disease: precursor\u2010product relationships in the derangement of neuronal function. Brain Pathol 1: 241\u2013251","journal-title":"Brain Pathol"},{"key":"BFEMMM201606210_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tips.2015.03.002","volume":"36","author":"K Blennow","year":"2015","unstructured":"Blennow K, Mattsson N, Scholl M, Hansson O, Zetterberg H (2015) Amyloid biomarkers in Alzheimer's disease. Trends Pharmacol Sci 36: 297\u2013309","journal-title":"Trends Pharmacol Sci"},{"key":"BFEMMM201606210_CR12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer\u2010related changes. Acta Neuropathol 82: 239\u2013259","journal-title":"Acta Neuropathol"},{"key":"BFEMMM201606210_CR13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ana.410350504","volume":"35","author":"P Brown","year":"1994","unstructured":"Brown P, Gibbs CJ, Rodgers\u2010Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35: 513\u2013529","journal-title":"Ann Neurol"},{"key":"BFEMMM201606210_CR14","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, Demattos RB, Patterson BW, Fagan AM, Morris JC, Mawuenyega KG, Cruchaga C et\u00a0al (2011) Human apoE isoforms differentially regulate brain amyloid\u2010\u03b2 peptide clearance. Sci Transl Med 3, 89ra57.","journal-title":"Sci Transl Med"},{"key":"BFEMMM201606210_CR15","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","volume":"31","author":"L Chavez\u2010Gutierrez","year":"2012","unstructured":"Chavez\u2010Gutierrez L, Bammens L, Benilova I, Vandersteen A, Benurwar M, Borgers M, Lismont S, Zhou L, Van Cleynenbreugel S, Esselmann H et\u00a0al (2012) The mechanism of gamma\u2010Secretase dysfunction in familial Alzheimer disease. EMBO J 31: 2261\u20132274","journal-title":"EMBO J"},{"key":"BFEMMM201606210_CR16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-122059","volume":"34","author":"DT Chien","year":"2013","unstructured":"Chien DT, Bahri S, Szardenings AK, Walsh JC, Mu F, Su MY, Shankle WR, Elizarov A, Kolb HC (2013) Early clinical PET imaging results with the novel PHF\u2010tau radioligand [F\u201018]\u2010T807. J Alzheimers Dis 34: 457\u2013468","journal-title":"J Alzheimers Dis"},{"key":"BFEMMM201606210_CR17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D'Avanzo C, Chen H, Hooli B, Asselin C, Muffat J et\u00a0al (2014) A three\u2010dimensional human neural cell culture model of Alzheimer's disease. Nature 515: 274\u2013278","journal-title":"Nature"},{"key":"BFEMMM201606210_CR18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak\u2010Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921\u2013923","journal-title":"Science"},{"key":"BFEMMM201606210_CR19","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archneurol.2012.2194","volume":"69","author":"V Coric","year":"2012","unstructured":"Coric V, van Dyck CH, Salloway S, Andreasen N, Brody M, Richter RW, Soininen H, Thein S, Shiovitz T, Pilcher G et\u00a0al (2012) Safety and tolerability of the gamma\u2010secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease. Arch Neurol 69: 1430\u20131440","journal-title":"Arch Neurol"},{"key":"BFEMMM201606210_CR20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.nbd.2013.02.003","volume":"54","author":"J Crehan","year":"2013","unstructured":"Crehan J, Hardy J, Pocock J (2013) Blockage of CR1 prevents activation of rodent microglia. Neurobiol Dis 54: 139\u2013149","journal-title":"Neurobiol Dis"},{"key":"BFEMMM201606210_CR21","unstructured":"Cummings J, Cho W, Ward M, Friesenhahn M, Brunstein F, Honigberg L, Clayton D, Mortensen D, Ho C, Paul R (2014) paper presented at the Alzheimer's Association International Conference (AAIC), Copenhagen, Denmark, 16 July 2014"},{"key":"BFEMMM201606210_CR22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cell.2014.10.016","volume":"159","author":"B De Strooper","year":"2014","unstructured":"De Strooper B (2014) Lessons from a failed gamma\u2010secretase Alzheimer trial. Cell 159: 721\u2013726","journal-title":"Cell"},{"key":"BFEMMM201606210_CR23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E (2016) The cellular phase of Alzheimer's disease. Cell 164: 603\u2013615","journal-title":"Cell"},{"key":"BFEMMM201606210_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B De Strooper","year":"1998","unstructured":"De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Gundula G, Annaert W, Von Figura K, Van Leuven F (1998) Deficiency of presenilin\u20101 inhibits the normal cleavage of amyloid precursor protein. Nature 391: 387\u2013390","journal-title":"Nature"},{"key":"BFEMMM201606210_CR25","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","volume":"76","author":"RB DeMattos","year":"2012","unstructured":"DeMattos RB, Lu J, Tang Y, Racke MM, Delong CA, Tzaferis JA, Hole JT, Forster BM, McDonnell PC, Liu F et\u00a0al (2012) A plaque\u2010specific antibody clears existing beta\u2010amyloid plaques in Alzheimer's disease mice. Neuron 76: 908\u2013920","journal-title":"Neuron"},{"key":"BFEMMM201606210_CR26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","volume":"369","author":"RS Doody","year":"2013","unstructured":"Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F, Sun X, Thomas RG et\u00a0al, Siemers E, Sethuraman G, Mohs R (2013) Semagacestat Study, a phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med 369, 341\u2013350","journal-title":"N Engl J Med"},{"key":"BFEMMM201606210_CR27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun Z, Aisen PS et\u00a0al, (2014). Phase 3 trials of solanezumab for mild\u2010to\u2010moderate Alzheimer's disease. N Engl J Med 370, 311\u2013321","journal-title":"N Engl J Med"},{"key":"BFEMMM201606210_CR28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.23748","volume":"73","author":"TJ Esparza","year":"2013","unstructured":"Esparza TJ, Zhao H, Cirrito JR, Cairns NJ, Bateman RJ, Holtzman DM, Brody DL (2013) Amyloid\u2010beta oligomerization in Alzheimer dementia versus high\u2010pathology controls. Ann Neurol 73: 104\u2013119","journal-title":"Ann Neurol"},{"key":"BFEMMM201606210_CR29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.92.3.763","volume":"92","author":"KC Evans","year":"1995","unstructured":"Evans KC, Berger EP, Cho CG, Weisgraber KH, Lansbury PT (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci USA 92: 763\u2013767","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201606210_CR30","doi-asserted-by":"crossref","first-page":"31043","DOI":"10.1074\/jbc.M114.581165","volume":"289","author":"MA Fernandez","year":"2014","unstructured":"Fernandez MA, Klutkowski JA, Freret T, Wolfe MS (2014) Alzheimer presenilin\u20101 mutations dramatically reduce trimming of long amyloid beta\u2010peptides (Abeta) by gamma\u2010secretase to increase 42\u2010to\u201040\u2010residue Abeta. J Biol Chem 289: 31043\u201331052","journal-title":"J Biol Chem"},{"key":"BFEMMM201606210_CR31","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","volume":"34","author":"P Forabosco","year":"2013","unstructured":"Forabosco P, Ramasamy A, Trabzuni D, Walker R, Smith C, Bras J, Levine AP, Hardy J, Pocock JM, Guerreiro R et\u00a0al (2013) Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol Aging 34: 2699\u20132714","journal-title":"Neurobiol Aging"},{"key":"BFEMMM201606210_CR32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F et\u00a0al (1995) Alzheimer\u2010type neuropathology in transgenic mice overexpressing V717F b\u2010amyloid precursor protein. Nature 373: 523\u2013527","journal-title":"Nature"},{"key":"BFEMMM201606210_CR33","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","volume":"64","author":"S Gilman","year":"2005","unstructured":"Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Rovira MB, Forette F et\u00a0al (2005) Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64: 1553\u20131562","journal-title":"Neurology"},{"key":"BFEMMM201606210_CR34","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"key":"BFEMMM201606210_CR35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano\u2010Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH, Hyman BT, Tanzi RE (2013) Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78: 631\u2013643","journal-title":"Neuron"},{"key":"BFEMMM201606210_CR36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S et\u00a0al (2013) TREM2 variants in Alzheimer's disease. N Engl J Med 368: 117\u2013127","journal-title":"N Engl J Med"},{"key":"BFEMMM201606210_CR37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/359322a0","volume":"359","author":"C Haass","year":"1992","unstructured":"Haass C, Schlossmacher M, Hung AY, Vigo\u2010Pelfrey C, Mellon A, Ostaszewski B, Lieberburg I, Koo EH, Schenk D, Teplow D et\u00a0al (1992) Amyloid beta\u2010peptide is produced by cultured cells during normal metabolism. Nature 359: 322\u2013325","journal-title":"Nature"},{"key":"BFEMMM201606210_CR38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends in Pharmac 12: 383\u2013388","journal-title":"Trends in Pharmac"},{"key":"BFEMMM201606210_CR39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353\u2013356","journal-title":"Science"},{"key":"BFEMMM201606210_CR40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins G (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184\u2013185","journal-title":"Science"},{"key":"BFEMMM201606210_CR41","doi-asserted-by":"crossref","first-page":"e8477","DOI":"10.1371\/journal.pone.0008477","volume":"4","author":"ML Hemming","year":"2009","unstructured":"Hemming ML, Elias JE, Gygi SP, Selkoe DJ (2009) Identification of beta\u2010secretase (BACE1) substrates using quantitative proteomics. PLoS ONE 4: e8477","journal-title":"PLoS ONE"},{"key":"BFEMMM201606210_CR42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo M, Abraham R, Hamshere ML, Pahwa JS, Moskvina V et\u00a0al (2011) Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43: 429\u2013435","journal-title":"Nat Genet"},{"key":"BFEMMM201606210_CR43","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius L, Mackey B, Olney J, McKeel D, Wozniak D et\u00a0al (2000) Apolipoprotein E isoform\u2010dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 97: 2892\u20132897","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201606210_CR44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuron.2014.02.027","volume":"82","author":"S Hong","year":"2014","unstructured":"Hong S, Ostaszewski BL, Yang T, O'Malley TT, Jin M, Yanagisawa K, Li S, Bartels T, Selkoe DJ (2014) Soluble Abeta oligomers are rapidly sequestered from brain ISF in\u00a0vivo and bind GM1 ganglioside on cellular membranes. Neuron 82: 308\u2013319","journal-title":"Neuron"},{"key":"BFEMMM201606210_CR45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Ekman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, A\u00df elevation, and amyloid plaques in transgenic mice. Science 274: 99\u2013102","journal-title":"Science"},{"issue":"Pt A","key":"BFEMMM201606210_CR46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","volume":"72","author":"Y Huang","year":"2014","unstructured":"Huang Y, Mahley RW (2014) Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol Dis 72 (Pt A), 3\u201312","journal-title":"Neurobiol Dis"},{"key":"BFEMMM201606210_CR47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jamaneurol.2013.1933","volume":"70","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM, Trojanowski JQ (2013) Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver\u2010derived human growth hormone. JAMA Neurol 70: 462\u2013468","journal-title":"JAMA Neurol"},{"key":"BFEMMM201606210_CR48","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","volume":"80","author":"CR Jack","year":"2013","unstructured":"Jack CR, Holtzman DM (2013) Biomarker modeling of Alzheimer's disease. Neuron 80: 1347\u20131358","journal-title":"Neuron"},{"key":"BFEMMM201606210_CR49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack","year":"2013","unstructured":"Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD et\u00a0al (2013) Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12: 207\u2013216","journal-title":"Lancet Neurol"},{"key":"BFEMMM201606210_CR50","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0092-8674(93)90635-4","volume":"73","author":"JT Jarrett","year":"1993","unstructured":"Jarrett JT, Lansbury PT (1993) Seeding \u201cone\u2010dimensional crystallization\u201d of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055\u20131058","journal-title":"Cell"},{"key":"BFEMMM201606210_CR51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature15369","volume":"525","author":"Z Jaunmuktane","year":"2015","unstructured":"Jaunmuktane Z, Mead S, Ellis M, Wadsworth JDF, Nicoll AJ, Kenny J, Launchbury F, Linehan J, Richard\u2010Loendt A, Walker AS et\u00a0al (2015) Evidence for human transmission of amyloid beta\u2010pathology and cerebral amyloid angiopathy. Nature 525: 247\u2013250","journal-title":"Nature"},{"key":"BFEMMM201606210_CR52","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1038\/npp.2014.164","volume":"39","author":"T Jiang","year":"2014","unstructured":"Jiang T, Tan L, Zhu XC, Zhang QQ, Cao L, Tan MS, Gu LZ, Wang HF, Ding ZZ, Zhang YD et\u00a0al (2014) Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease. Neuropsychopharmacology 39: 2949\u20132962","journal-title":"Neuropsychopharmacology"},{"key":"BFEMMM201606210_CR53","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ (2011) Soluble amyloid beta\u2010protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci USA 108: 5819\u20135824","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201606210_CR54","doi-asserted-by":"crossref","first-page":"e13950","DOI":"10.1371\/journal.pone.0013950","volume":"5","author":"L Jones","year":"2010","unstructured":"Jones L, Holmans PA, Hamshere ML, Harold D, Moskvina V, Ivanov D, Pocklington A, Abraham R, Hollingworth P, Sims R et\u00a0al (2010) Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS ONE 5: e13950","journal-title":"PLoS ONE"},{"key":"BFEMMM201606210_CR55","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J et\u00a0al (2012) A mutation in APP protects against Alzheimer's disease and age\u2010related cognitive decline. Nature 488: 96\u201399","journal-title":"Nature"},{"key":"BFEMMM201606210_CR56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ et\u00a0al (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368: 107\u2013116","journal-title":"N Engl J Med"},{"key":"BFEMMM201606210_CR57","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1038\/ncomms4386","volume":"5","author":"K Kanatsu","year":"2014","unstructured":"Kanatsu K, Morohashi M, Suzuki Y, Kuroda H, Watanabe T, Tomita T, Iwatsubo T (2014) Decreased CALM expression reduces Abeta42 to total Abeta ratio through clathrin\u2010mediated endocytosis of gamma\u2010secretase. Nat Commun 5: 3386","journal-title":"Nat Commun"},{"key":"BFEMMM201606210_CR58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ana.24188","volume":"76","author":"E Karran","year":"2014","unstructured":"Karran E, Hardy J (2014) A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease. Ann Neurol 76: 185\u2013205","journal-title":"Ann Neurol"},{"issue":"1518","key":"BFEMMM201606210_CR59","first-page":"e1511","volume":"34","author":"M Kero","year":"2013","unstructured":"Kero M, Paetau A, Polvikoski T, Tanskanen M, Sulkava R, Jansson L, Myllykangas L, Tienari PJ (2013) Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population. Neurobiol Aging 34(1518): e1511\u2013e1513","journal-title":"Neurobiol Aging"},{"key":"BFEMMM201606210_CR60","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","volume":"27","author":"J Kim","year":"2007","unstructured":"Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, Dickson DW, Golde T, McGowan E (2007) Abeta40 inhibits amyloid deposition in\u00a0vivo. J Neurosci 27: 627\u2013633","journal-title":"J Neurosci"},{"key":"BFEMMM201606210_CR61","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1523\/JNEUROSCI.4165-12.2013","volume":"33","author":"WS Kim","year":"2013","unstructured":"Kim WS, Li H, Ruberu Chan KS, Elliott DA, Low JK, Cheng D, Karl T, Garner B (2013) Deletion of Abca7 increases cerebral amyloid\u2010beta accumulation in the J20 mouse model of Alzheimer's disease. J Neurosci 33: 4387\u20134394","journal-title":"J Neurosci"},{"key":"BFEMMM201606210_CR62","doi-asserted-by":"crossref","first-page":"243ra286","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, Yamanishi Y, Suarez\u2010Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger\u2010Weinzier A, Mazaheri F et\u00a0al (2014) TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med 6, 243ra286","journal-title":"Sci Transl Med"},{"key":"BFEMMM201606210_CR63","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S et\u00a0al (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound\u2010B. Ann Neurol 55: 306\u2013319","journal-title":"Ann Neurol"},{"key":"BFEMMM201606210_CR64","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer\u2010Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia\u2010Alloza M, Micheva KD, Smith SJ, Kim ML, Lee VM et\u00a0al (2009) Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA 106: 4012\u20134017","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201606210_CR65","doi-asserted-by":"publisher","unstructured":"Kretner B, Trambauer J, Fukumori A, Mielke J, Kuhn PH, Kremmer E, Giese A, Lichtenthaler SF, Haass C, Arzberger T et\u00a0al (2016). Generation and deposition of A\u00df43 by the virtually inactive presenilin\u20101 L435F mutant contradicts the presenilin loss of function hypothesis of Alzheimer's disease. EMBO Mol Med doi:https:\/\/doi.org\/10.15252\/emmm.201505952","DOI":"10.15252\/emmm.201505952"},{"key":"BFEMMM201606210_CR66","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/emboj.2012.173","volume":"31","author":"PH Kuhn","year":"2012","unstructured":"Kuhn PH, Koroniak K, Hogl S, Colombo A, Zeitschel U, Willem M, Volbracht C, Schepers U, Imhof A, Hoffmeister A et\u00a0al (2012) Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J 31: 3157\u20133168","journal-title":"EMBO J"},{"key":"BFEMMM201606210_CR67","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B et\u00a0al (2009) Genome\u2010wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094\u20131099","journal-title":"Nat Genet"},{"key":"BFEMMM201606210_CR68","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim\u2010Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStefano AL, Bis JC, Beecham GW, Grenier\u2010Boley B et\u00a0al (2013) Meta\u2010analysis of 74,046 individuals identifies 11 new susceptibility loci for\u00a0Alzheimer's disease. Nat Genet 45: 1452\u20131458","journal-title":"Nat Genet"},{"key":"BFEMMM201606210_CR69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","volume":"3","author":"CA Lemere","year":"1996","unstructured":"Lemere CA, Blustzjan JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ (1996a) Sequence of deposition of heterogeneous amyloid b\u2010peptides and Apo E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3: 16\u201332","journal-title":"Neurobiol Dis"},{"key":"BFEMMM201606210_CR70","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm1096-1146","volume":"2","author":"CA Lemere","year":"1996","unstructured":"Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, Yamaguchi H, Ruiz A, Martinez A, Madrigal L et\u00a0al (1996b) The E280A presenilin 1 Alzheimer mutation produces increased Ab42 deposition and severe cerebellar pathology. Nature Med 2: 1146\u20131150","journal-title":"Nature Med"},{"key":"BFEMMM201606210_CR201","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","volume":"25","author":"J Lewis","year":"2000","unstructured":"Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn\u2010Hardy K, Paul Murphy M, Baker M, Yu X et al (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25: 402\u2013405","journal-title":"Nat Genet"},{"key":"BFEMMM201606210_CR71","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D et\u00a0al (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293: 1487\u20131491","journal-title":"Science"},{"key":"BFEMMM201606210_CR72","doi-asserted-by":"publisher","DOI":"10.2310\/7290.2014.00025","volume-title":"Mol Imaging","author":"SH Liang","year":"2014","unstructured":"Liang SH, Yokell DL, Normandin MD, Rice PA, Jackson RN, Shoup TM, Brady TJ, El Fakhri G, Collier TL, Vasdev N (2014) First human use of a radiopharmaceutical prepared by continuous\u2010flow microfluidic radiofluorination: proof of concept with the tau imaging agent [18F]T807. Mol Imaging 13: doi:https:\/\/doi.org\/10.2310\/7290.2014.00025"},{"key":"BFEMMM201606210_CR73","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuroscience.2014.09.050","volume":"302","author":"LF Lue","year":"2015","unstructured":"Lue LF, Schmitz C, Walker DG (2015) What happens to microglial TREM2 in Alzheimer's disease: immunoregulatory turned into immunopathogenic? Neuroscience 302: 138\u2013150","journal-title":"Neuroscience"},{"key":"BFEMMM201606210_CR74","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/372092a0","volume":"372","author":"J Ma","year":"1994","unstructured":"Ma J, Yee A, Brewer HB, Das S, Potter H (1994) The amyloid\u2010associated proteins a1\u2010antichymotrypsin and apolipoprotein E promote the assembly of the Alzheimer b\u2010protein into filaments. Nature 372: 92\u201394","journal-title":"Nature"},{"key":"BFEMMM201606210_CR75","doi-asserted-by":"crossref","first-page":"30990","DOI":"10.1074\/jbc.M114.589069","volume":"289","author":"JA Maloney","year":"2014","unstructured":"Maloney JA, Bainbridge T, Gustafson A, Zhang S, Kyauk R, Steiner P, van der Brug M, Liu Y, Ernst JA, Watts RJ et\u00a0al (2014) Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein. J Biol Chem 289: 30990\u201331000","journal-title":"J Biol Chem"},{"key":"BFEMMM201606210_CR76","first-page":"201","volume":"1","author":"DMA Mann","year":"1992","unstructured":"Mann DMA, Yuonis N, Jones D, Stoddart DW (1992) The time course of pathological events in Down's Syndrome with particular reference to the involvement of microglial cells and deposits of b\/A4. Neurodegeneration 1: 201\u2013215","journal-title":"Neurodegeneration"},{"key":"BFEMMM201606210_CR77","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","volume":"79","author":"M Maruyama","year":"2013","unstructured":"Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang MR, Trojanowski JQ, Lee VM, Ono M et\u00a0al (2013) Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79: 1094\u20131108","journal-title":"Neuron"},{"key":"BFEMMM201606210_CR78","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","volume":"10","author":"M Matarin","year":"2015","unstructured":"Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, Nahaboo Solim MA, Moens TG, Paublete RM, Ali SS et\u00a0al (2015) A genome\u2010wide gene\u2010expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep 10: 633\u2013644","journal-title":"Cell Rep"},{"key":"BFEMMM201606210_CR79","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta\u2010amyloid in Alzheimer's disease. Science 330: 1774\u20131777","journal-title":"Science"},{"key":"BFEMMM201606210_CR80","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1017\/S0317167100029863","volume":"16","author":"PL McGeer","year":"1989","unstructured":"McGeer PL, Akiyama H, Itagaki S, McGreer EG (1989) Immune system response in Alzheimer's disease. Can J Neurol Sci 16: 516\u2013627","journal-title":"Can J Neurol Sci"},{"key":"BFEMMM201606210_CR81","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.celrep.2015.03.068","volume":"11","author":"S Moore","year":"2015","unstructured":"Moore S, Evans LD, Andersson T, Portelius E, Smith J, Dias TB, Saurat N, McGlade A, Kirwan P, Blennow K et\u00a0al (2015) APP metabolism regulates tau proteostasis in human cerebral cortex neurons. Cell Rep 11: 689\u2013696","journal-title":"Cell Rep"},{"key":"BFEMMM201606210_CR82","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1016\/S0021-9258(18)41896-0","volume":"267","author":"H Mori","year":"1992","unstructured":"Mori H, Takio K, Ogawara M, Selkoe DJ (1992) Mass spectrometry of purified amyloid b protein in Alzheimer's disease. J Biol Chem 267: 17082\u201317086","journal-title":"J Biol Chem"},{"key":"BFEMMM201606210_CR83","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/hmg\/ddu064","volume":"23","author":"MR Muratore","year":"2014","unstructured":"Muratore MR, Rice HC, Srikanth P, Callahan DG, Shin T, Benjamin LN, Walsh DM, Selkoe DJ, Young\u2010Pearse TL (2014) The familial Alzheimer's disease APPV717I mutation alters APP processing and tau expression in iPSC\u2010derived neurons. Hum Mol Genet 23: 3523\u20133536","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201606210_CR84","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature11060","volume":"485","author":"JM Nussbaum","year":"2012","unstructured":"Nussbaum JM, Schilling S, Cynis H, Silva A, Swanson E, Wangsanut T, Tayler K, Wiltgen B, Hatami A, Ronicke R et\u00a0al (2012) Prion\u2010like behaviour and tau\u2010dependent cytotoxicity of pyroglutamylated amyloid\u2010beta. Nature 485: 651\u2013655","journal-title":"Nature"},{"key":"BFEMMM201606210_CR85","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.celrep.2012.11.028","volume":"3","author":"M Okochi","year":"2013","unstructured":"Okochi M, Tagami S, Yanagida K, Takami M, Kodama TS, Mori K, Nakayama T, Ihara Y, Takeda M (2013) Gamma\u2010secretase modulators and presenilin 1 mutants act differently on presenilin\/gamma\u2010secretase function to cleave Abeta42 and Abeta43. Cell Rep 3: 42\u201351","journal-title":"Cell Rep"},{"key":"BFEMMM201606210_CR86","doi-asserted-by":"crossref","first-page":"189ra177","DOI":"10.1126\/scitranslmed.3005615","volume":"5","author":"R Potter","year":"2013","unstructured":"Potter R, Patterson BW, Elbert DL, Ovod V, Kasten T, Sigurdson W, Mawuenyega K, Blazey T, Goate A, Chott R et\u00a0al (2013). Increased in\u00a0vivo amyloid\u2010beta42 production, exchange, and loss in presenilin mutation carriers. Sci Transl Med 5, 189ra177.","journal-title":"Sci Transl Med"},{"key":"BFEMMM201606210_CR87","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.410430316","volume":"43","author":"VP Prasher","year":"1998","unstructured":"Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, Barber PC, Butler AC (1998) Molecular mapping of Alzheimer\u2010type dementia in Down's syndrome. Ann Neurol 43: 380\u2013383","journal-title":"Ann Neurol"},{"key":"BFEMMM201606210_CR88","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.1575-04.2005","volume":"25","author":"Y Qi\u2010Takahara","year":"2005","unstructured":"Qi\u2010Takahara Y, Morishima\u2010Kawashima M, Tanimura Y, Dolios G, Hirotani N, Horikoshi Y, Kametani F, Maeda M, Saido TC, Wang R et\u00a0al (2005) Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma\u2010secretase. J Neurosci 25: 436\u2013445","journal-title":"J Neurosci"},{"key":"BFEMMM201606210_CR89","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1073\/pnas.092136199","volume":"99","author":"M Rapoport","year":"2002","unstructured":"Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A (2002) Tau is essential to beta \u2010amyloid\u2010induced neurotoxicity. Proc Natl Acad Sci USA 99: 6364\u20136369","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201606210_CR90","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","volume":"11","author":"GW Rebeck","year":"1993","unstructured":"Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11: 575\u2013580","journal-title":"Neuron"},{"key":"BFEMMM201606210_CR91","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","volume":"7","author":"LM Refolo","year":"2000","unstructured":"Refolo LM, Malester B, LaFrancois J, Bryant\u2010Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA (2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7: 321\u2013331","journal-title":"Neurobiol Dis"},{"key":"BFEMMM201606210_CR92","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","volume":"8","author":"LM Refolo","year":"2001","unstructured":"Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas\u2010Bryant T, Tint GS, Wang R, Mercken M, Petanceska SS et\u00a0al (2001) A cholesterol\u2010lowering drug reduces beta\u2010amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 8: 890\u2013899","journal-title":"Neurobiol Dis"},{"key":"BFEMMM201606210_CR93","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00702-005-0385-2","volume":"113","author":"RM Ridley","year":"2006","unstructured":"Ridley RM, Baker HF, Windle CP, Cummings RM (2006) Very long term studies of the seeding of beta\u2010amyloidosis in primates. J Neural Transm 113: 1243\u20131251","journal-title":"J Neural Transm"},{"key":"BFEMMM201606210_CR94","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2011","unstructured":"Roberson ED, Scearce\u2010Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2011) Reducing endogenous tau ameliorates amyloid beta\u2010induced deficits in an Alzheimer's disease mouse model. Science 316: 750\u2013754","journal-title":"Science"},{"key":"BFEMMM201606210_CR95","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H et\u00a0al (2007) The neuronal sortilin\u2010related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39: 168\u2013177","journal-title":"Nat Genet"},{"key":"BFEMMM201606210_CR96","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet\u2010Lecrux","year":"2006","unstructured":"Rovelet\u2010Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M et\u00a0al (2006) APP locus duplication causes autosomal dominant early\u2010onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38: 24\u201326","journal-title":"Nat Genet"},{"key":"BFEMMM201606210_CR97","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N, Saido TC (2014) Single App knock\u2010in mouse models of Alzheimer's disease. Nat Neurosci 17: 661\u2013663","journal-title":"Nat Neurosci"},{"key":"BFEMMM201606210_CR98","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nn.2858","volume":"14","author":"T Saito","year":"2011","unstructured":"Saito T, Suemoto T, Brouwers N, Sleegers K, Funamoto S, Mihira N, Matsuba Y, Yamada K, Nilsson P, Takano J et\u00a0al (2011) Potent amyloidogenicity and pathogenicity of Abeta43. Nat Neurosci 14: 1023\u20131032","journal-title":"Nat Neurosci"},{"key":"BFEMMM201606210_CR99","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson\u2010Wood K, Khan K et\u00a0al (1999) Immunization with amyloid\u2010\u00df attenuates Alzheimer\u2010disease\u2010like pathology in the PDAPP mouse. Nature 400: 173\u2013177","journal-title":"Nature"},{"key":"BFEMMM201606210_CR100","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W et\u00a0al (1996) Secreted amyloid b\u2010protein similar to that in the senile plaques of Alzheimer's disease is increased in\u00a0vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 2: 864\u2013870","journal-title":"Nature Med"},{"key":"BFEMMM201606210_CR101","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","volume":"6","author":"DJ Selkoe","year":"1991","unstructured":"Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487\u2013498","journal-title":"Neuron"},{"key":"BFEMMM201606210_CR102","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2460","volume":"17","author":"DJ Selkoe","year":"2011","unstructured":"Selkoe DJ (2011) Resolving controversies on the path to Alzheimer's therapeutics. Nat Med 17: 1060\u20131065","journal-title":"Nat Med"},{"key":"BFEMMM201606210_CR103","volume-title":"The Biology of Alzheimer Disease","author":"DJ Selkoe","year":"2012","unstructured":"Selkoe DJ, Mandelkow E, Holtzman DM (2012) The Biology of Alzheimer Disease. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press"},{"key":"BFEMMM201606210_CR104","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/brain\/awq056","volume":"133","author":"A Serrano\u2010Pozo","year":"2010","unstructured":"Serrano\u2010Pozo A, William CM, Ferrer I, Uro\u2010Coste E, Delisle MB, Maurage CA, Hock C, Nitsch RM, Masliah E, Growdon JH et\u00a0al (2010) Beneficial effect of human anti\u2010amyloid\u2010beta active immunization on neurite morphology and tau pathology. Brain 133, 1312\u20131327","journal-title":"Brain"},{"issue":"Suppl 1","key":"BFEMMM201606210_CR105","first-page":"311","volume":"15","author":"J Sevigny","year":"2015","unstructured":"Sevigny J, Chiao P, Williams L, Miao X, O'Gorman J (2015) Randomized, double\u2010blind Phase 1B study of BIIB037, an anti\u2010amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer's disease. Neurogener Dis 15(Suppl 1): 311","journal-title":"Neurogener Dis"},{"key":"BFEMMM201606210_CR106","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia\u2010Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA et\u00a0al (2008) Amyloid\u2010beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14: 837\u2013842","journal-title":"Nat Med"},{"key":"BFEMMM201606210_CR107","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1073\/pnas.0608332104","volume":"104","author":"J Shen","year":"2007","unstructured":"Shen J, Kelleher RJ (2007) The presenilin hypothesis of Alzheimer's disease: evidence for a loss\u2010of\u2010function pathogenic mechanism. Proc Natl Acad Sci USA 104: 403\u2013409","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201606210_CR108","first-page":"124","volume":"4","author":"Y Shi","year":"2012","unstructured":"Shi Y, Kirwan P, Smith J, MacLean G, Orkin SH, Livesey FJ (2012) A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Sci Transl Med 4: 124\u2013129","journal-title":"Sci Transl Med"},{"key":"BFEMMM201606210_CR109","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","volume":"60","author":"SA Small","year":"2008","unstructured":"Small SA, Duff K (2008) Linking Abeta and tau in late\u2010onset Alzheimer's disease: a dual pathway hypothesis. Neuron 60: 534\u2013542","journal-title":"Neuron"},{"key":"BFEMMM201606210_CR110","doi-asserted-by":"crossref","first-page":"228fs213","DOI":"10.1126\/scitranslmed.3007941","volume":"6","author":"RA Sperling","year":"2014","unstructured":"Sperling RA, Rentz DM, Johnson KA, Karlawish J, Donohue M, Salmon DP, Aisen P (2014) The A4 study: stopping AD before symptoms begin? Sci Transl Med 6, 228fs213","journal-title":"Sci Transl Med"},{"key":"BFEMMM201606210_CR111","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ng.3246","volume":"47","author":"S Steinberg","year":"2015","unstructured":"Steinberg S, Stefansson H, Jonsson T, Johannsdottir H, Ingason A, Helgason H, Sulem P, Magnusson OT, Gudjonsson SA, Unnsteinsdottir U et\u00a0al (2015) Loss\u2010of\u2010function variants in ABCA7 confer risk of Alzheimer's disease. Nat Genet 47: 445\u2013447","journal-title":"Nat Genet"},{"key":"BFEMMM201606210_CR112","doi-asserted-by":"publisher","unstructured":"Su\u00e1rez\u2010Calvet M, Kleinberger G, Araque Caballero M\u00c1, Brendel M, Rominger A, Alcolea D, Fortea J, Lle\u00f3 A, Blesa R, Gispert JD et\u00a0al (2016) sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early\u2010stage Alzheimer's disease and associate with neuronal injury markers. EMBO Mol Med 2016 doi: https:\/\/doi.org\/10.15252\/emmm.201506123","DOI":"10.15252\/emmm.201506123"},{"key":"BFEMMM201606210_CR113","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1084\/jem.20150892","volume":"212","author":"M Szaruga","year":"2015","unstructured":"Szaruga M, Veugelen S, Benurwar M, Lismont S, Sepulveda\u2010Falla D, Lleo A, Ryan NS, Lashley T, Fox NC, Murayama S et\u00a0al (2015) Qualitative changes in human gamma\u2010secretase underlie familial Alzheimer's disease. J Exp Med 212: 2003\u20132013","journal-title":"J Exp Med"},{"key":"BFEMMM201606210_CR114","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","volume":"29","author":"M Takami","year":"2009","unstructured":"Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima\u2010Kawashima M, Funamoto S, Ihara Y (2009) gamma\u2010Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta\u2010carboxyl terminal fragment. J Neurosci 29: 13042\u201313052","journal-title":"J Neurosci"},{"key":"BFEMMM201606210_CR115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-9-20","volume":"9","author":"JD Ulrich","year":"2014","unstructured":"Ulrich JD, Finn MB, Wang Y, Shen A, Mahan TE, Jiang H, Stewart FR, Piccio L, Colonna M, Holtzman DM (2014) Altered microglial response to Abeta plaques in APPPS1\u201021 mice heterozygous for TREM2. Mol Neurodegener 9: 20","journal-title":"Mol Neurodegener"},{"key":"BFEMMM201606210_CR116","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1212\/WNL.45.4.788","volume":"45","author":"C Vigo\u2010Pelfrey","year":"1995","unstructured":"Vigo\u2010Pelfrey C, Seubert P, Barbour R, Blomquist C, Lee M, Lee D, Coria F, Chang L, Miller B, Lieberburg I et\u00a0al (1995) Elevation of microtubule\u2010associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology 45: 788\u2013793","journal-title":"Neurology"},{"key":"BFEMMM201606210_CR117","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P et\u00a0al (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol 12: 357\u2013367","journal-title":"Lancet Neurol"},{"key":"BFEMMM201606210_CR118","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson KJ, Ulrich JD, Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S, Zinselmeyer BH et\u00a0al (2015) TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 160: 1061\u20131071","journal-title":"Cell"},{"key":"BFEMMM201606210_CR119","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1021\/bi5003053","volume":"53","author":"AT Welzel","year":"2014","unstructured":"Welzel AT, Maggio JE, Shankar GM, Walker DE, Ostaszewski BL, Li S, Klyubin I, Rowan MJ, Seubert P, Walsh DM et\u00a0al (2014) Secreted amyloid beta\u2010proteins in a cell culture model include N\u2010terminally extended peptides that impair synaptic plasticity. Biochemistry 53: 3908\u20133921","journal-title":"Biochemistry"},{"key":"BFEMMM201606210_CR120","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.1132341","volume":"314","author":"M Willem","year":"2006","unstructured":"Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, De Strooper B, Saftig P, Birchmeier C, Haass C (2006) Control of peripheral nerve myelination by the beta\u2010secretase BACE1. Science 314: 664\u2013666","journal-title":"Science"},{"key":"BFEMMM201606210_CR121","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature14864","volume":"526","author":"M Willem","year":"2015","unstructured":"Willem M, Tahirovic S, Busche MA, Ovsepian SV, Chafai M, Kootar S, Hornburg D, Evans LD, Moore S, Daria A et\u00a0al (2015) \u03b7\u2010Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature 526: 433\u2013447","journal-title":"Nature"},{"key":"BFEMMM201606210_CR122","first-page":"1030","volume":"145","author":"T Wisniewski","year":"1994","unstructured":"Wisniewski T, Castano AM, Golabek A, Vogel T, Frangione B (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in\u00a0vitro. Am J Pathol 145: 1030\u20131035","journal-title":"Am J Pathol"},{"key":"BFEMMM201606210_CR123","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ (1999) Two transmembrane aspartates in presenilin\u20101 required for presenilin endoproteolysis and g\u2010secretase activity. Nature 398: 513\u2013517","journal-title":"Nature"},{"key":"BFEMMM201606210_CR124","doi-asserted-by":"crossref","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","volume":"288","author":"P Wunderlich","year":"2013","unstructured":"Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J (2013) Sequential proteolytic processing of the triggering receptor expressed on myeloid cells\u20102 (TREM2) protein by ectodomain shedding and gamma\u2010secretase\u2010dependent intramembranous cleavage. J Biol Chem 288: 33027\u201333036","journal-title":"J Biol Chem"},{"key":"BFEMMM201606210_CR125","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuron.2015.02.010","volume":"85","author":"D Xia","year":"2015","unstructured":"Xia D, Watanabe H, Wu B, Lee SH, Li Y, Tsvetkov E, Bolshakov VY, Shen J, Kelleher RJ (2015) Presenilin\u20101 knockin mice reveal loss\u2010of\u2010function mechanism for familial Alzheimer's disease. Neuron 85: 967\u2013981","journal-title":"Neuron"},{"key":"BFEMMM201606210_CR126","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.stem.2015.02.004","volume":"16","author":"JE Young","year":"2015","unstructured":"Young JE, Boulanger\u2010Weill J, Williams DA, Woodruff G, Buen F, Revilla AC, Herrera C, Israel MA, Yuan SH, Edland SD et\u00a0al (2015) Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell 16: 373\u2013385","journal-title":"Cell Stem Cell"},{"key":"BFEMMM201606210_CR127","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, Zhang C, Xie T, Tran L, Dobrin R et\u00a0al (2013) Integrated systems approach identifies genetic nodes and networks in late\u2010onset Alzheimer's disease. Cell 153: 707\u2013720","journal-title":"Cell"},{"key":"BFEMMM201606210_CR128","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nn.4025","volume":"18","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Sagare AP, Ma Q, Halliday MR, Kong P, Kisler K, Winkler EA, Ramanathan A, Kanekiyo T, Bu G et\u00a0al (2015) Central role for PICALM in amyloid\u2010beta blood\u2013brain barrier transcytosis and clearance. Nat Neurosci 18: 978\u2013987","journal-title":"Nat Neurosci"},{"key":"BFEMMM201606210_CR129","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1021\/acschemneuro.5b00171","volume":"6","author":"X Zheng","year":"2015","unstructured":"Zheng X, Liu D, Roychaudhuri R, Teplow DB, Bowers MT (2015) Amyloid beta\u2010protein assembly: differential effects of the protective A2T mutation and recessive A2V familial Alzheimer's disease mutation. ACS Chem Neurosci 6: 1732\u20131740","journal-title":"ACS Chem Neurosci"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201606210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201606210","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201606210\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201606210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201606210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:19:54Z","timestamp":1779085194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201606210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":130,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6,1]]}},"alternative-id":["BFEMMM201606210"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201606210","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,29]]},"assertion":[{"value":"11 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DS is a director of Prothena Biosciences and has received consulting fees from Janssen, Roche, and Sanofi and a speaker's fee from Biogen\u2010Idec. JH consults for Eisai and for Cytox and has received speaking fees from Eli Lilly, Takeda, and Roche.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}